Orthostatic hypotension: Difference between revisions
Norina Usman (talk | contribs) |
Norina Usman (talk | contribs) |
||
Line 103: | Line 103: | ||
Common [[Risk factor|risk factors]] in the development of orthostatic hypotension include:<ref name="ArnoldShibao2013">{{cite journal|last1=Arnold|first1=Amy C.|last2=Shibao|first2=Cyndya|title=Current Concepts in Orthostatic Hypotension Management|journal=Current Hypertension Reports|volume=15|issue=4|year=2013|pages=304–312|issn=1522-6417|doi=10.1007/s11906-013-0362-3}}</ref><ref name="CanobbioWarnes2017">{{cite journal|last1=Canobbio|first1=Mary M.|last2=Warnes|first2=Carole A.|last3=Aboulhosn|first3=Jamil|last4=Connolly|first4=Heidi M.|last5=Khanna|first5=Amber|last6=Koos|first6=Brian J.|last7=Mital|first7=Seema|last8=Rose|first8=Carl|last9=Silversides|first9=Candice|last10=Stout|first10=Karen|title=Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association|journal=Circulation|volume=135|issue=8|year=2017|issn=0009-7322|doi=10.1161/CIR.0000000000000458}}</ref> | Common [[Risk factor|risk factors]] in the development of orthostatic hypotension include:<ref name="ArnoldShibao2013">{{cite journal|last1=Arnold|first1=Amy C.|last2=Shibao|first2=Cyndya|title=Current Concepts in Orthostatic Hypotension Management|journal=Current Hypertension Reports|volume=15|issue=4|year=2013|pages=304–312|issn=1522-6417|doi=10.1007/s11906-013-0362-3}}</ref><ref name="CanobbioWarnes2017">{{cite journal|last1=Canobbio|first1=Mary M.|last2=Warnes|first2=Carole A.|last3=Aboulhosn|first3=Jamil|last4=Connolly|first4=Heidi M.|last5=Khanna|first5=Amber|last6=Koos|first6=Brian J.|last7=Mital|first7=Seema|last8=Rose|first8=Carl|last9=Silversides|first9=Candice|last10=Stout|first10=Karen|title=Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association|journal=Circulation|volume=135|issue=8|year=2017|issn=0009-7322|doi=10.1161/CIR.0000000000000458}}</ref> | ||
*[[Age]] ( | *[[Age]] (>65) | ||
*[[Medication|Medications]] ([[Alpha blocker|alpha blockers]]) | *[[Medication|Medications]] ([[Alpha blocker|alpha blockers]]) | ||
*[[Disease]]: [[Parkinson's Disease|Parkinson's disease]], [[diabetes]] | *[[Disease]]: [[Parkinson's Disease|Parkinson's disease]], [[diabetes]] |
Revision as of 16:39, 23 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Synonyms and keywords: Postural hypotension; orthostatic intolerance; head rush; dizzy spell
Overview
Orthostatic hypotension is a physical finding demarcated by the American Academy of Neurology and the American Autonomic Society as a reduction in systolic blood pressure of 20 mm Hg or a drop of 10 mm Hg in diastolic blood pressure within three minutes of standing compared with blood pressure from the sitting or supine position. Orthostatic hypotension is frequently found in frail patients and those who are older.2 It is noticed in up to 20 percent of patients older than 65 years [1][2][3].
Classification
Initial orthostatic hypotension (iOH)
It is most common in healthy adolescents and is demarcated as a brief BP decrease of >40 mmHg systolic or >20 mmHg diastolic with symptomatic cerebral hypoperfusion within five to fifteen seconds after standing, typically resolves by twenty seconds.
Neurogenic orthostatic hypotension (nOH)
In Neurogenic orthostatic hypotension, the sympathetic noradrenergic nerves continually fail to facilitate the reflexive cardiovascular responses essential to sustain blood pressure in response to orthostatic stress. It is described as a constant BP decrease of >20 mmHg systolic or >10 mmHg diastolic, without or with symptoms, within three minutes of head-up tilt or standing.
Delayed orthostatic hypotension (dOH)
Delayed orthostatic hypotension (dOH) is demarcated as a fall in blood pressure that accomplishes neurogenic orthostatic hypotension criteria but ensues after three minutes.
Neurally mediated syncope (vOH)
It is also recognized as vasodepressor or vasovagal syncope, It involves a paroxysmal extraction of sympathetic vasopressor tone, frequently during prolonged standing, in patients with an effective autonomic nervous system.
Cardiovascular orthostatic hypotension (cOH)
Cardiovascular orthostatic hypotension occurs from intravascular hypovolemia or reduced cardiac output along with compensatory tachycardia.
Orthostatic pseudohypotension (pOH)
It is stated as apparent orthostatic hypotension when baseline supine blood pressure is raised, which may be due to a short time at rest to create a valid baseline, related recumbent hypertension, or fluctuation of baseline blood pressure with labile hypertension[4][5][6][7].
Pathophysiology
- In standing position, 300 to 800 mL of blood pools in the lower extremities. Preservation of blood pressure while changing the position requires many organs like cardiac, neurologic, vascular, muscular, and neurohumoral to respond rapidly.9 If any of these responses are irregular, organ perfusion and blood pressure can be reduced. Therefore, symptoms of central nervous system hypoperfusion may arise, including nausea, weakness, dizziness, headache, lightheadedness, fatigue, blurred vision, palpitations, tremulousness, vertigo, and impaired cognition.
- The autonomic nervous system plays a significant role in sustaining blood pressure when a person changes position. The sympathetic nervous system regulates the tone in the heart, arteries, and veins.
- Baroreceptors located mainly in the aorta and carotid arteries are very sensitive to fluctuations in blood pressure. As soon as the baroreceptors sense the minor decrease in blood pressure, a synchronized increase in sympathetic stimulation occurs. Arteries contract to increase blood pressure and peripheral resistance, and subsequently increases heart rate and contractility.
- All of these responses are designed to sustain perfusion and blood pressure. Additional physiologic mechanisms can also be involved including the renin-angiotensin-aldosterone system, low-pressure receptors in the heart and lungs, the systemic release of norepinephrine, and vasopressin.
- Over-all, all parts of the nervous systems and cardiovascular must work together. If there is insufficient intravascular volume, a decrease of venous return, impairment of the autonomic nervous system, or the heart's incapability to pump with the higher power, orthostatic hypotension may result[8][9][10][11][12].
Causes
Common Causes
Common causes of orthostatic hypotension may include:
- Medical conditions:
- Pregnancy
- Heart problems: Bradycardia, heart valve problems, heart attack and heart failure.
- Dehydration: Fever, vomiting, severe diarrhea, overuse of diuretics and strenuous exercise can lead to dehydration.
- Endocrine problems
- Blood loss
- Septicemia
- Aanaphylaxis: reaction include foods, certain medications, insect venoms and latex.
- Anemia: Lack of nutrients (vitamins B-12, folate)
- Medication:
- Apomorphine hydrochloride
- Bromocriptine
- Cidofovir
- Entacapone
- Ethacrynic Acid
- Fluphenazine
- Hydrochlorothiazide
- Iloperidone
- Loxapine
- Niacin
- Pergolide
- Perphenazine
- Rasagiline
- Risperidone
- Ritonavir
- Rotigotine
- Thioridazine hydrochloride
- Thiothixene,
- Tiagabine
- Vincristine sulfate liposome
- Diuretics especially furosemide, Lisinopril and Hydrochlorothiazide
- Beta Blockers,
- Calcium channel blockers
- ACE Inhibitors
- Prazosin
- Tamsulosin
- Nitrates
- Anti-psychotics Clozapine, zotepine, Olanzapine,
- Neuroleptics
- Sedative hypnotics
- Anti-depressants,duloxetine,tricyclics
- MAOIs
- Pramipexole
- Ropinirole[13][14][15][16].
Risk Factors
Common risk factors in the development of orthostatic hypotension include:[17][18]
- Age (>65)
- Medications (alpha blockers)
- Disease: Parkinson's disease, diabetes
- Postpartum period
- Prolong bedrest.
Natural History
- The symptoms of orthostatic hypotension usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
- The symptoms of (disease name) typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
Common complications of orthostatic hypotension include:[19][20]
- Moderate low blood pressure:
- Severely low blood pressure:
- Heart damage (Heart failur)
- Brian damage (Stroke)
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
- Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
Diagnosis
History and Symptoms
Symptoms, which generally occur after sudden standing, include dizziness, lightheadedness, headache, blurred or dimmed vision (possibly to the point of momentary blindness), and fainting. They are consequences of insufficient blood pressure and cerebral perfusion(blood supply).
Symptoms
Physical Examination
- Patients with orthostatic hypotension usually appear well, pallor and tiredness. [24]
- Physical examination may be remarkable for:
- Fall in blood pressure, typically greater than 20/10 mm
Treatment
Medical Therapy
There are medications to treat hypotension. In addition, there are many lifestyle advices. Many of them, however, are specific for a certain cause of orthostatic hypotension.
Some drugs that are used in the treatment of orthostatic hypotension include fludrocortisone (Florinef), erythropoietin and midodrine. Pyridostigmine bromide (Mestinon) is now also used to treat orthostatic hypotension.[25][26][27]
- Treatment of neurogenic orthostatic hypotension:[28]
- Avoid triggers: large meals, hot bath, prolong standig
Lifestyle Advice
Some suggestions for minimizing the effects include:
- Checking blood pressure regularly with a home monitoring kit. Check when lying flat and when standing as well as when symptoms occur.
- Standing slowly rather than quickly, as the delay can give the blood vessels more time to constrict properly. This can help avoid incidents of syncope (fainting).
- Take a deep breath and flex your abdominal muscles while rising to maintain blood and oxygen in the brain. This, however, may be contraindicated in individuals with Stage 3 hypertension. Usually medical personnel have their patients "dangle" before rising from bed to decrease the likelihood of dizziness / falling due to orthostatic hypotension. The dangling is done by having the patient sit on the side of their bed for about a minute so they do not have the sudden dizziness.
- Maintaining an elevated salt intake, through sodium supplements or electrolyte-enriched drinks. A suggested value is 10 g per day; overuse can lead to hypertension and should be avoided.
- Maintaining a proper fluid intake to prevent the effects of dehydration.
- As eating lowers blood pressure, eat multiple smaller meals rather than fewer larger meals. Take extra care when standing after eating.
- When orthostatic hypotension is caused by hypovolemia due to medications, the disorder may be reversed by adjusting the dosage or by discontinuing the medication.
- When the condition is caused by prolonged bed rest, improvement may occur by sitting up with increasing frequency each day. In some cases, physical counterpressure such as elastic hose or whole-body inflatable suits may be required.
References
- ↑ Bradley JG, Davis KA (2003). "Orthostatic hypotension". Am Fam Physician. 68 (12): 2393–8. PMID 14705758.
- ↑ Rutan GH, Hermanson B, Bild DE, Kittner SJ, LaBaw F, Tell GS (1992). "Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group". Hypertension. 19 (6 Pt 1): 508–19. doi:10.1161/01.hyp.19.6.508. PMID 1592445.
- ↑ Ooi WL, Barrett S, Hossain M, Kelley-Gagnon M, Lipsitz LA (1997). "Patterns of orthostatic blood pressure change and their clinical correlates in a frail, elderly population". JAMA. 277 (16): 1299–304. PMID 9109468.
- ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.1007/s10286-016-0382-6 Check
|pmid=
value (help). - ↑ Wieling W, Krediet CT, van Dijk N, Linzer M, Tschakovsky ME (2007). "Initial orthostatic hypotension: review of a forgotten condition". Clin Sci (Lond). 112 (3): 157–65. doi:10.1042/CS20060091. PMID 17199559.
- ↑ Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I; et al. (2011). "Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome". Clin Auton Res. 21 (2): 69–72. doi:10.1007/s10286-011-0119-5. PMID 21431947.
- ↑ Wieling W, Schatz IJ (2009). "The consensus statement on the definition of orthostatic hypotension: a revisit after 13 years". J Hypertens. 27 (5): 935–8. doi:10.1097/HJH.0b013e32832b1145. PMID 19390349.
- ↑ Lipsitz LA (1989). "Orthostatic hypotension in the elderly". N Engl J Med. 321 (14): 952–7. doi:10.1056/NEJM198910053211407. PMID 2674714.
- ↑ Low PA, Opfer-Gehrking TL, McPhee BR, Fealey RD, Benarroch EE, Willner CL; et al. (1995). "Prospective evaluation of clinical characteristics of orthostatic hypotension". Mayo Clin Proc. 70 (7): 617–22. doi:10.4065/70.7.617. PMID 7791382.
- ↑ Zaqqa M, Massumi A (2000). "Neurally mediated syncope". Tex Heart Inst J. 27 (3): 268–72. PMC 101078. PMID 11093411.
- ↑ Mathias CJ (1995). "Orthostatic hypotension: causes, mechanisms, and influencing factors". Neurology. 45 (4 Suppl 5): S6–11. PMID 7746371.
- ↑ Hollister AS (1992). "Orthostatic hypotension. Causes, evaluation, and management". West J Med. 157 (6): 652–7. PMC 1022100. PMID 1475949.
- ↑ Jiang W, Davidson JR. (2005). "Antidepressant therapy in patients with ischemic heart disease". Am Heart J. 150 (5): 871–81. PMID 16290952.
- ↑ Delini-Stula A, Baier D, Kohnen R, Laux G, Philipp M, Scholz HJ. (1999). "Undesirable blood pressure changes under naturalistic treatment with moclobemide, a reversible MAO-A inhibitor--results of the drug utilization observation studies". Pharmacopsychiatry. 32 (2): 61–7. PMID 10333164.
- ↑ Jones RT. (2002). "Cardiovascular system effcts of marijuana". J Clin Pharmacol. 42 (11 Suppl): 58S–63S. PMID 12412837.
- ↑ Hohmann M, Künzel W (1991). "Orthostatic hypotension and birthweight". Arch. Gynecol. Obstet. 248 (4): 181–9. doi:10.1007/bf02390357. PMID 1898124.
- ↑ Arnold, Amy C.; Shibao, Cyndya (2013). "Current Concepts in Orthostatic Hypotension Management". Current Hypertension Reports. 15 (4): 304–312. doi:10.1007/s11906-013-0362-3. ISSN 1522-6417.
- ↑ Canobbio, Mary M.; Warnes, Carole A.; Aboulhosn, Jamil; Connolly, Heidi M.; Khanna, Amber; Koos, Brian J.; Mital, Seema; Rose, Carl; Silversides, Candice; Stout, Karen (2017). "Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association". Circulation. 135 (8). doi:10.1161/CIR.0000000000000458. ISSN 0009-7322.
- ↑ Romero-Ortuno R, Cogan L, Foran T, Kenny RA, Fan CW (April 2011). "Continuous noninvasive orthostatic blood pressure measurements and their relationship with orthostatic intolerance, falls, and frailty in older people". J Am Geriatr Soc. 59 (4): 655–65. doi:10.1111/j.1532-5415.2011.03352.x. PMID 21438868.
- ↑ Ricci, Fabrizio; Fedorowski, Artur; Radico, Francesco; Romanello, Mattia; Tatasciore, Alfonso; Di Nicola, Marta; Zimarino, Marco; De Caterina, Raffaele (2015). "Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies". European Heart Journal. 36 (25): 1609–1617. doi:10.1093/eurheartj/ehv093. ISSN 0195-668X.
- ↑ Bleasdale-Barr KM, Mathias CJ (July 1998). "Neck and other muscle pains in autonomic failure: their association with orthostatic hypotension". J R Soc Med. 91 (7): 355–9. doi:10.1177/014107689809100704. PMC 1296807. PMID 9771493.
- ↑ Khurana RK (July 2012). "Coat-hanger ache in orthostatic hypotension". Cephalalgia. 32 (10): 731–7. doi:10.1177/0333102412449932. PMID 22711896.
- ↑ Robertson D, Kincaid DW, Haile V, Robertson RM (June 1994). "The head and neck discomfort of autonomic failure: an unrecognized aetiology of headache". Clin. Auton. Res. 4 (3): 99–103. doi:10.1007/bf01845772. PMID 7994169.
- ↑ Stewart JM (May 2013). "Common syndromes of orthostatic intolerance". Pediatrics. 131 (5): 968–80. doi:10.1542/peds.2012-2610. PMC 3639459. PMID 23569093.
- ↑ Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. (2003). "Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension". J Neurol Neurosurg Psychiatry. 74 (9): 1294–8. PMID 12933939.
- ↑ Figueroa, J. J.; Basford, J. R.; Low, P. A. (2010). "Preventing and treating orthostatic hypotension: As easy as A, B, C". Cleveland Clinic Journal of Medicine. 77 (5): 298–306. doi:10.3949/ccjm.77a.09118. ISSN 0891-1150.
- ↑ Freeman, Roy; Abuzinadah, Ahmad R.; Gibbons, Christopher; Jones, Pearl; Miglis, Mitchell G.; Sinn, Dong In (2018). "Orthostatic Hypotension". Journal of the American College of Cardiology. 72 (11): 1294–1309. doi:10.1016/j.jacc.2018.05.079. ISSN 0735-1097.
- ↑ Freeman, Roy; Abuzinadah, Ahmad R.; Gibbons, Christopher; Jones, Pearl; Miglis, Mitchell G.; Sinn, Dong In (2018). "Orthostatic Hypotension". Journal of the American College of Cardiology. 72 (11): 1294–1309. doi:10.1016/j.jacc.2018.05.079. ISSN 0735-1097.
External Links
- John G. Bradley, M.D., and Kathy A. Davis, R.N. Orthostatic Hypotension American Family Physician
- DYNA Dysautonomia Youth Network of America, Inc.